Innovus Pharmaceuticals (INNV): Price and Financial Metrics

Innovus Pharmaceuticals (INNV): $23.09

-0.18 (-0.77%)

POWR Rating

Component Grades













INNV Stock Price Chart Interactive Chart >

Price chart for INNV

INNV Price/Volume Stats

Current price $23.09 52-week high $27.18
Prev. close $23.27 52-week low $19.46
Day low $21.46 Volume 1,055,300
Day high $23.46 Avg. volume 293,316
50-day MA $22.94 Dividend yield N/A
200-day MA $0.00 Market Cap 3.13B

Innovus Pharmaceuticals (INNV) Company Bio

Innovus Pharmaceuticals is an over-the-counter (OTC) consumer goods and pharmaceutical company engaged in the commercialization, licensing and development of safe and non-prescription medicine, consumer care products, supplements and medical devices to improve men's and women's health and vitality. Co.'s products focuses on six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. Co. delivers health solutions of OTC medicines, devices, consumer and health products, and clinical supplements through four general channels including Direct to Consumer Marketing, E-Commerce, Retail/Wholesale, and International Distribution.

INNV Latest News Stream

Event/Time News Detail
Loading, please wait...

INNV Latest Social Stream

Loading social stream, please wait...

View Full INNV Social Stream

Latest INNV News From Around the Web

Below are the latest news stories about InnovAge Holding Corp that investors may wish to consider to help them evaluate INNV as an investment opportunity.

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Does the June share price for InnovAge Holding Corp. ( NASDAQ:INNV ) reflect what it's really worth? Today, we will...

Yahoo | June 6, 2021

InnovAge to Participate in Upcoming Investor Conferences

DENVER, May 26, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced that Maureen Hewitt, Chief Executive Officer, and Barb Gutierrez, Chief Financial Officer, will participate in the William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021, including a virtual fireside chat presentation at 5:00 p.m. (ET). The company will also participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, including a virtual fireside chat presentation on Wednesday, June 9, 2021 at 5:30 p.m. (ET). The appearance will be webcast live, and the webcast links and related presentation materials for these conferences wil...

Yahoo | May 26, 2021

InnovAge to Announce Third Quarter 2021 Financial Results and Host Conference Call Monday, May 10, 2021

DENVER, April 26, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) will release its 2021 third quarter financial results on Monday, May 10, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsThe conference call can be accessed by dialing (833) 398-1024 for U.S. participants, or (914) 987-7722 for international participants, and referencing participant code 7594282. A live audio webcast will be available online at A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 12 months. About InnovAgeInnov...

Yahoo | April 26, 2021

Senior care provider InnovAge rises in public debut

Senior care provider InnovAge started trading today under the ticker "INNV." InnovAge CEO Maureen Hewitt joins Yahoo Finance live to discuss the company’s IPO and what’s in store for 2021.

Yahoo | March 4, 2021

Read More 'INNV' Stories Here

INNV Price Returns

1-mo 11.82%
3-mo -5.41%
6-mo N/A
1-year N/A
3-year 101.75%
5-year -6.82%
2020 0.00%
2019 -87.41%
2018 -19.40%
2017 -57.93%
2016 183.57%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8421 seconds.